Rebecca Panks

Power

Increase in electricity prices during COVID-19 might help Egypt restructure the economy and eventually remove subsidies beyond 2024-2025, says GlobalData

Egypt’s plan of cutting down on subsidies came after the devaluation of the national currency, post the three-year IMF program. As a likely measure to remove subsidies beyond 2024-2025, the Egyptian Ministry of Energy increased the electricity consumption costs for the residential sector by between 17% to 30% (19.1% average). The measure earlier was expected […]

Banking

Brazil’s struggling economy sees consumers turn to safer investments, says GlobalData

Brazilians are seeking the shelter of retail deposits, as its already weak economy has been shaken by the COVID-19 crisis, according to GlobalData. The pandemic has brought its economy to a standstill, which has caused sharp declines in the financial markets GlobalData’s senior wealth management analyst, Heike Van Den Hoevel, commented: “The ongoing loss of […]

Banking

Switzerland’s retail savings and investment market to recover quickly from COVID-19 impact, says GlobalData

The Swiss retail savings and investments market will see a slight downturn in 2020, with retail equity and mutual fund holdings taking the brunt of the economy’s slowdown, according to GlobalData. GlobalData forecasts double-digit growth declines for both retail equity and mutual fund holdings, of 17.2% and 11.1% respectively. However, retail equity holdings are expected […]

Insurance

Insurers’ reliance on investments make them vulnerable due to COVID-19, says GlobalData

Investments made by insurers are vulnerable to the economic impacts caused by COVID-19. With a combination of volatility in financial markets, the increasing cost of claims and a looming economic recession increasing the pressure on insurers’ balance sheets, says GlobalData, a leading data and analytics company. GlobalData’s senior insurance analyst, Daniel Pearce, commented: “The pressure […]

Power

COVID-19 pandemic expected to reduce power consumption in US commercial and industrial sectors by more than 4%, says GlobalData

In the US, the pandemic is pulling down peak loads and the on-peak and off-peak hourly prices in many regional markets. Going ahead, US utilities’ cost of capital is likely to increase due to the increased volatility and cost-recovery risks, says GlobalData, a leading data and analytics company. Somik Das, Senior Power Analyst at GlobalData, […]

Oil & Gas

Lowering oil & gas price assumptions an important lever towards cleaner investment for BP post-COVID-19, says GlobalData

Following BP’s announcement that it is revising long term price assumptions as part of its strategy development; Will Scargill, Managing Oil & Gas Analyst at GlobalData, a leading data and analytics company, offers his view on the company’s latest steps: “BP’s decision to revise downwards its long-term oil and gas price assumptions is an important […]

Pharma

MDMA’s efficacy data likely to support FDA approval after studies did not lead to drug abuse, says GlobalData

Following the publication of a new study of the long-term effectiveness of midomafetamine (MDMA) for the treatment of post-traumatic stress disorder (PTSD); Philippa Salter, Neurology Analyst at GlobalData, a leading data and analytics company, offers her view: “New long-term data for MDMA as a treatment for PTSD adds to the evidence of the effectiveness of […]

Power

Wind project approval delays to hinder UK from achieving offshore capacity and emission reduction targets, says GlobalData

Delays in project approvals is likely to hinder the UK from achieving offshore wind capacity and emission reduction targets within the specified deadline. While there are no tangible signs that the UK Government’s long-term commitment to offshore wind is wavering, the delays in approval decisions are agitating developers, says GlobalData, a leading data and analytics […]

Pharma

COVID-19 accelerates innovations in pharma industry and FDA, says GlobalData

The global COVID-19 pandemic has become a catalyst for the pharma industry and the US Food and Drug Administration (FDA) to implement long-awaited innovations. The urgent manufacturing needs caused by the pandemic and the requirement for social distancing are driving pharma companies and regulators to finally deploy advanced technologies that have been suggested for years […]

Power

Norway funds and bets on hydrogen as likely means to provide a green transition to a sustainable future, says GlobalData

Norway’s plan to invest US$384.5m as a green transition package is likely to aid the country on economic and environmental fronts. The environmental support would allow the country to achieve the Paris Climate Agreement target of limiting global temperature rise to less than two degrees by 2050. Alternatively, the economic thrust would help the country […]

Pharma

COVID-19 disruption of clinical trials starting to slow, says GlobalData

More than 200 trials that were previously disrupted from the COVID-19 pandemic by delayed initiation and slow or suspended enrollment are now ongoing or completed. This represents a 3.2-times increase compared to last month. This upward trend for clinical trial delays may begin to slow further as more companies adjust to conducting clinical trials during […]

Pharma

Future of over 320 hydroxychloroquine trials is now uncertain, says GlobalData

Following today’s news (Monday 15 June) that the FDA has pulled emergency use authorization of hydroxychloroquine for COVID-19; Johanna Swanson, Product Manager at GlobalData, a leading data and analytics company, offers her view: “GlobalData expects the number of withdrawn or terminated hydroxychloroquine clinical trials will increase in the coming month. This news leaves an uncertain […]

Pharma

Moderna’s forecast sales dependent on mRNA-1273 vaccine for COVID-19, says GlobalData

Moderna’s mRNA-1273 vaccine for COVID-19 is currently in Phase I development and is targeted for an aggressive commercial launch in 2021. The vaccine candidate’s peak US sales are currently estimated to reach $17.72B in 2026, meaning mRNA-1273 would account for 90–95% of Moderna’s forecast revenue. As such, mRNA-1273 could be a sales leader for COVID-19, […]

Pharma

Gilead likely preparing for remdesivir approval and launch by ramping up hiring from January to March 2020, says GlobalData

Gilead is likely preparing for remdesivir’s approval and launch, based on an analysis of GlobalData’s Job Analytics database. As an operational reaction to the COVID-19 pandemic, Gilead ramped up hiring from January to March in 2020. However, there was a slight decline in April. Still, this accounted for one of the largest hiring increases in […]

Aerospace, Defense & Security

Bombardier distances itself from commercial aviation with valid reasons, says GlobalData

Following the news that Bombardier is planning to cut 600 jobs at its Belfast facility manufacturing A220 wings; Nicolas Jouan, Aerospace and Defense Analyst at GlobalData, a leading data and analytics company, offers his view on Bombardier’s decision: “Bombardier’s move to cut up to 2,500 jobs in its aviation business, of which 600 are based […]

Technology

Sony’s leadership in gaming services will help it control next-generation console market, says GlobalData

Following the first reveal of Sony’s next-generation PlayStation 5 console; Rupantar Guha, Senior Analyst of Thematic Research at GlobalData, a leading data and analytics company, shares his views: “The next-generation gaming consoles will increasingly pivot around added-value services. With limited differentiation in hardware, both Sony and Microsoft will need to focus on platform-exclusive titles, subscriptions […]

Medical Devices

Guidelines for non-emergency elective procedures are released

Following the Centers for Medicare & Medicaid Services (CMS) announcement that guidelines to resume elective procedures for healthcare systems were released: Kamilla Kan, Medical Analyst at GlobalData, a leading data and analytics company, offers her view on the recent news: “In March CMS has released recommendations for healthcare providers to postpone non-emergency elective procedures in […]

Construction

French construction industry to contract by 9.4% in 2020, says GlobalData

The construction industry in France is expected to shrink by 9.4% in 2020, according to GlobalData, a leading data and analytics company. This is despite the fact that the construction sector was exempted from the nationwide lockdown that had been in place since mid-March. Danny Richards, Lead Economist at GlobalData commented: “Despite the easing of […]

Power

Dominance of wind projects in second CfD auctions highlights troubles of Italian solar PV market, says GlobalData

The ban of solar projects developed on farmlands and Italy’s complicated permit rules are the likely reasons for diminishing interest in solar PV development, says GlobalData, a leading data and analytics company. This puts a strain on the country’s need to simplify authorization, which will aid the growth of the sector. Somik Das, Power Analyst […]

Insurance

Cycling boom a rare opportunity for insurers during pandemic, says GlobalData

Demand for bicycle insurance is set to soar as consumers look to avoid public transport during the pandemic, and digitally savvy insurers should capitalize. GlobalData research shows that the demand for bicycle insurance has increased in recent years, although it is still not a particularly common product. However, demand will increase as people return to […]

Prev 1 … 54 55 56 57 58 … 77 Next

Increase in electricity prices during COVID-19 might help Egypt restructure the economy and eventually remove subsidies beyond 2024-2025, says GlobalData

Brazil’s struggling economy sees consumers turn to safer investments, says GlobalData

Switzerland’s retail savings and investment market to recover quickly from COVID-19 impact, says GlobalData

Insurers’ reliance on investments make them vulnerable due to COVID-19, says GlobalData

COVID-19 pandemic expected to reduce power consumption in US commercial and industrial sectors by more than 4%, says GlobalData

Lowering oil & gas price assumptions an important lever towards cleaner investment for BP post-COVID-19, says GlobalData

MDMA’s efficacy data likely to support FDA approval after studies did not lead to drug abuse, says GlobalData

Wind project approval delays to hinder UK from achieving offshore capacity and emission reduction targets, says GlobalData

COVID-19 accelerates innovations in pharma industry and FDA, says GlobalData

Norway funds and bets on hydrogen as likely means to provide a green transition to a sustainable future, says GlobalData

COVID-19 disruption of clinical trials starting to slow, says GlobalData

Future of over 320 hydroxychloroquine trials is now uncertain, says GlobalData

Moderna’s forecast sales dependent on mRNA-1273 vaccine for COVID-19, says GlobalData

Gilead likely preparing for remdesivir approval and launch by ramping up hiring from January to March 2020, says GlobalData

Bombardier distances itself from commercial aviation with valid reasons, says GlobalData

Sony’s leadership in gaming services will help it control next-generation console market, says GlobalData

Guidelines for non-emergency elective procedures are released

French construction industry to contract by 9.4% in 2020, says GlobalData

Dominance of wind projects in second CfD auctions highlights troubles of Italian solar PV market, says GlobalData

Cycling boom a rare opportunity for insurers during pandemic, says GlobalData

Browse

Company information